Compare NPCE & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | DNUT |
|---|---|---|
| Founded | 1997 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.6M | 606.8M |
| IPO Year | 2021 | 2021 |
| Metric | NPCE | DNUT |
|---|---|---|
| Price | $16.06 | $3.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $18.33 | $4.15 |
| AVG Volume (30 Days) | 147.3K | ★ 2.3M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $99,986,000.00 | ★ $1,522,616,000.00 |
| Revenue This Year | $0.90 | $0.55 |
| Revenue Next Year | $24.46 | $3.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $2.58 |
| 52 Week High | $19.60 | $5.73 |
| Indicator | NPCE | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 65.58 |
| Support Level | $15.40 | $3.11 |
| Resistance Level | $17.37 | $4.11 |
| Average True Range (ATR) | 0.80 | 0.17 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 27.15 | 87.95 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.